Celldex Therapeutics reported $229.98M in Equity Capital and Reserves for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Abbvie ABBV:US $ 13076M 2194M
Amgen AMGN:US $ 9409M 1550M
Applied Genetic Technologies AGTC:US $ 41.52M 14.68M
Aptinyx Inc APTX:US $ 109.79M 7.52M
Biocept BIOC:US $ 21.35M 4.73M
Bristol Myers Squibb BMY:US $ 37822M 12336M
Celldex Therapeutics CLDX:US $ 229.98M 8.47M
Glaxosmithkline GSK:US $ 14587M 301M
Immunogen IMGN:US $ 89.57M 132.46M
Nektar Therapeutics NKTR:US $ 1077.3M 93.69M
Newlink Genetics NLNK:US $ 118.54M 2.07M
Pfizer PFE:US $ 63238M 2021M
Rigel Pharmaceuticals RIGL:US $ 50.96M 12.26M
Seattle Genetics SGEN:US $ 3488.1M 1230.07M